Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

5,430 trials

Showing 20 of 5,430 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05547464
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 497
Testing effectiveness (Phase 2)Study completedNCT04032093
What this trial is testing

A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

Who this might be right for
Respiratory Tract Infection
Pfizer 1,153
Large-scale testing (Phase 3)Study completedNCT01053143
What this trial is testing

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India

Who this might be right for
InfluenzaPandemic InfluenzaInfluenza A Virus, H1N1 Subtype
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT03038776
What this trial is testing

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Who this might be right for
Influenza, Avian
Vaxine Pty Ltd 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT07113106
What this trial is testing

Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteers
ANRS, Emerging Infectious Diseases 48
Testing effectiveness (Phase 2)Looking for participantsNCT07509047
What this trial is testing

Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children

Who this might be right for
Cholera Vaccination
International Vaccine Institute 390
Testing effectiveness (Phase 2)Study completedNCT00874549
What this trial is testing

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Sanofi Pasteur, a Sanofi Company 216
Early research (Phase 1)Study completedNCT00320658
What this trial is testing

Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT06438978
What this trial is testing

Tuberculosis Vaccine in Healthy Indian Adults

Who this might be right for
Tuberculosis
Bharat Biotech International Limited 30
Early research (Phase 1)WithdrawnNCT02385825
What this trial is testing

IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost

Who this might be right for
Ricin Poisoning
U.S. Army Medical Research and Development Command
Early research (Phase 1)Study completedNCT03163121
What this trial is testing

Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers

Who this might be right for
Malaria
Sanaria Inc. 67
Very early researchStudy completedNCT06837116
What this trial is testing

Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers

Who this might be right for
Dengue
Prince of Songkla University 29
Large-scale testing (Phase 3)Study completedNCT00139347
What this trial is testing

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 6,360
Testing effectiveness (Phase 2)Study completedNCT04882514
What this trial is testing

A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.

Who this might be right for
Group A Streptococcal Infection
University of Alberta 30
Large-scale testing (Phase 3)Study completedNCT00652743
What this trial is testing

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

Who this might be right for
Influenza
GlaxoSmithKline 845
Testing effectiveness (Phase 2)Study completedNCT00126984
What this trial is testing

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 508
Testing effectiveness (Phase 2)Study completedNCT00437021
What this trial is testing

MVA Post-Event: Administration Timing and Boost Study

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 226
Early research (Phase 1)Study completedNCT00001906
What this trial is testing

Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants

Who this might be right for
Cutaneous Leishmaniasis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT01122784
What this trial is testing

Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

Who this might be right for
Plague Vaccine
DynPort Vaccine Company LLC, A GDIT Company 402
Testing effectiveness (Phase 2)Looking for participantsNCT05868733
What this trial is testing

A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa

Who this might be right for
Lassa Fever
International AIDS Vaccine Initiative 612
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation